The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1972, 109: 348-352.
Copyright © 1972 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kirchner, H.
Right arrow Articles by Hofstrand, H. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kirchner, H.
Right arrow Articles by Hofstrand, H. J.

Defective in Vitro Spleen Cell Proliferative Response to Antigens in Agammaglobulinemic Chickens

H. Kirchner1, J. J. Oppenheim, M. R. Blaese and H. J. Hofstrand

From the National Institutes of Health, National Institute of Dental Research and National Cancer Institute, Bethesda, Maryland 20014

Abstract

Cyclophosphamide treatment of chickens during early extraembryonic life selectively inactivates B cells as indicated by the induction of agammaglobulinemia and the lack of proliferative response of their spleen cells to anti-immunoglobulin. T cell functions as measured by the response to phytomitogens, anti-thymocyte serum and irradiated allogeneic cells in the mixed leukocyte reaction were found to be intact. However, the in vitro proliferative response to specific antigens was significantly diminished in agammaglobulinemic chickens which suggests that B cell participation may be required for this response.

Footnotes

1 Supported by a training grant from the Deutsche Forschungsgemeinschaft.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1972 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1972 by The American Association of Immunologists, Inc. All rights reserved.